Membership of Board Committees
| Board member | Audit & Risk | Corporate administration and transactions | Corporate responsibility | Nominations | Remuneration | Science |
|---|---|---|---|---|---|---|
| Sir Philip Hampton | Member | Chairman | ||||
| Emma Walmsley | Member | |||||
| Simon Dingemans | Member | |||||
| Dr Hal Barron | Member | |||||
| Manvinder Singh (Vindi) Banga | Member | Member | Member | Member | ||
| Dr Vivienne Cox | Member | Member | Member | |||
| Lynn Elsenhans | Member | Member | Chair | Member | ||
| Dr Laurie Glimcher | Member | Member | Member | |||
| Dr Jesse Goodman | Member | Member | Chairman | |||
| Judy Lewent | Chair | Member | Member | Member | Member | |
| Urs Rohner | Member | Member | Chairman |
Find out more about the board
-
Role of the Board
The Board is accountable to shareholders for ensuring that GSK is appropriately managed and achieves the strategic objectives it sets
-
Independence of Non-Executive Directors
Our Board considers all of its Non-Executive Directors to be independent in character and judgement
-
The roles of our Chairman and Chief Executive Officer
Sir Philip Hampton is the Chairman of our Board and Emma Walmsley is our Chief Executive Officer (CEO)
-
Directors' contracts
See our Executive Directors' contracts of service, Non-Executive Directors' letters of appointment and information on document inspection
